Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Oncocyte Corp (OCX)

1.395   0.025 (1.82%) 09-29 10:09
Open: 1.38 Pre. Close: 1.37
High: 1.4 Low: 1.35
Volume: 12,332 Market Cap: 94M
OncoCyte Corp. is a pharmaceutical company. The company is headquartered in Alameda, California and currently employs 12 full-time employees. The firm is developing molecular cancer diagnostics utilizing a discovery platform that focuses on identifying genetic markers expressed in various types of cancer. The company operates through the research and development of diagnostic tests for the detection of cancer segment. Its initial focus will be confirmatory diagnostics, utilizing liquid biopsy technology, for use in conjunction with imaging to confirm initial diagnoses within certain oncology indications. In addition, it will be developing screening diagnostics as replacements for screening imaging procedures. For some indications, it will also be pursuing the probability of recurrence of a specific cancer through the development of prognostics or companion diagnostics that help a physician determine which therapy is the optimal treatment for the patient. The company offers diagnostic tests for lung, breast and bladder cancer.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.391 - 1.401 1.401 - 1.409
Low: 1.292 - 1.302 1.302 - 1.31
Close: 1.357 - 1.372 1.372 - 1.385

Technical analysis

as of: 2020-09-28 4:35:50 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 1.70     One year: 1.92
Support: Support1: 1.15    Support2: 0.96
Resistance: Resistance1: 1.45    Resistance2: 1.64
Pivot: 1.39
Moving Average: MA(5): 1.32     MA(20): 1.35
MA(100): 1.93     MA(250): 2.07
MACD: MACD(12,26): -0.04     Signal(9): -0.04
Stochastic oscillator: %K(14,3): 33.89     %D(3): 29.37
RSI: RSI(14): 48.19
52-week: High: 3.51  Low: 1.15  Change(%): -30.5
Average Vol(K): 3-Month: 95166  10-Days: 62229

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
OCX has closed above bottom band by 44.5%. Bollinger Bands are 67.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to OCX's normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 28 Sep 2020
$OCX Oncocyte Corp Terminated Chief Operating Officer's Employment as Part Of Cost Savings Plan - CML News

Wed, 23 Sep 2020
Stocks To Trade: OncoCyte Corporation (OCX) Attracting Wallstreet Traders - Invest Million

Fri, 18 Sep 2020
Is OncoCyte Corp (OCX) the Top Pick in the Biotechnology Industry? - InvestorsObserver

Thu, 17 Sep 2020
What is the Forecast Price for OncoCyte Corp (OCX) Stock? - InvestorsObserver

Thu, 10 Sep 2020
OncoCyte Corporation (NYSE:OCX) Crashes -5% In 2020; Is It Attractive Enough At $1.35? - Marketing Sentinel

Thu, 10 Sep 2020
OncoCyte Corp (NYSEAMERICAN:OCX) and the Guardian Research Network® Collaborate to Establish an Integrated Platform for Precision Medicine Clinical Trials - BP Journal

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 67
Shares Float (M) 34
% Held by Insiders 17.92
% Held by Institutions 34.54
Shares Short (K) 1,230
Shares Short P. Month (K) 1,170

Stock Financials

EPS -0.478
EPS Est This Year -0.540
EPS Est Next Year -0.540
Book Value (p.s.) 0.590
Profit Margin
Operating Margin -164206.25
Return on Assets (ttm) -32.5
Return on Equity (ttm) -70.3
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.386
Qtrly Earnings Growth
Operating Cash Flow (M) -20
Levered Free Cash Flow (M) -10

Stock Valuations

PE Ratio -2.87
PEG Ratio
Price to Book value 2.32
Price to Sales 5755.71
Price to Cash Flow -4.63

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.